Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjian Min

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|March 9, 2026
Rational Design of Potent and Orally Efficacious PI3Kα/δ Degrader for PIK3CA Mutant Breast Cancer without Hyperglycemic LiabilityYi Hou, Xinqing Zheng, Yiwen Zhang, et al.
Journal of Medicinal Chemistry|February 27, 2024
Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule InhibitorsChengliang Sun, Yuling He, Gefei Wang, et al.
Journal of Medicinal Chemistry|December 27, 2021
Discovery of Dual CDK6/PIM1 Inhibitors with a Novel Structure, High Potency, and Favorable Druggability for the Treatment of Acute Myeloid LeukemiaKai Yuan, Minghui Ji, Shengnan Xie, et al.
International Journal of Biological Sciences|June 16, 2023
Limonin, a natural ERK2 agonist, protects against ischemic acute kidney injuryXianke Zhou, Yadie Xiang, Dier Li, et al.
Leukemia|December 20, 2024
ADAR1 is required for acute myeloid leukemia cell survival by modulating post-transcriptional Wnt signaling through impairing miRNA biogenesisZhongrui Shi, Jiaxing Li, Jiayu Ding, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 20, 2025
ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PALLD-Mediated EMT Signaling PathwayJiayu Ding, Hao Shen, Jiaying Ji, et al.
Acta Pharmaceutica Sinica. B|December 23, 2022
Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agentsChengliang Sun, Yao Cheng, Xiaojia Liu, et al.
Nature Communications|May 25, 2022
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancerKai Yuan, Zhaoxing Li, Wenbin Kuang, et al.
The Journal of Clinical Investigation|May 7, 2024
Fibroblast expression of transmembrane protein smoothened governs microenvironment characteristics after acute kidney injuryYuan Gui, Haiyan Fu, Zachary Palanza, et al.
Cell Death and Differentiation|June 17, 2022
B7-1 mediates podocyte injury and glomerulosclerosis through communication with Hsp90ab1-LRP5-β-catenin pathwayJiemei Li, Jing Niu, Wenjian Min, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|March 9, 2026
Rational Design of Potent and Orally Efficacious PI3Kα/δ Degrader for PIK3CA Mutant Breast Cancer without Hyperglycemic LiabilityYi Hou, Xinqing Zheng, Yiwen Zhang, et al.
Journal of Medicinal Chemistry|February 27, 2024
Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule InhibitorsChengliang Sun, Yuling He, Gefei Wang, et al.
Journal of Medicinal Chemistry|December 27, 2021
Discovery of Dual CDK6/PIM1 Inhibitors with a Novel Structure, High Potency, and Favorable Druggability for the Treatment of Acute Myeloid LeukemiaKai Yuan, Minghui Ji, Shengnan Xie, et al.
International Journal of Biological Sciences|June 16, 2023
Limonin, a natural ERK2 agonist, protects against ischemic acute kidney injuryXianke Zhou, Yadie Xiang, Dier Li, et al.
Leukemia|December 20, 2024
ADAR1 is required for acute myeloid leukemia cell survival by modulating post-transcriptional Wnt signaling through impairing miRNA biogenesisZhongrui Shi, Jiaxing Li, Jiayu Ding, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 20, 2025
ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PALLD-Mediated EMT Signaling PathwayJiayu Ding, Hao Shen, Jiaying Ji, et al.
Acta Pharmaceutica Sinica. B|December 23, 2022
Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agentsChengliang Sun, Yao Cheng, Xiaojia Liu, et al.
Nature Communications|May 25, 2022
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancerKai Yuan, Zhaoxing Li, Wenbin Kuang, et al.
The Journal of Clinical Investigation|May 7, 2024
Fibroblast expression of transmembrane protein smoothened governs microenvironment characteristics after acute kidney injuryYuan Gui, Haiyan Fu, Zachary Palanza, et al.
Cell Death and Differentiation|June 17, 2022
B7-1 mediates podocyte injury and glomerulosclerosis through communication with Hsp90ab1-LRP5-β-catenin pathwayJiemei Li, Jing Niu, Wenjian Min, et al.
Pageof 5